These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17308306)

  • 1. The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation.
    Textoris-Taube K; Henklein P; Pollmann S; Bergann T; Weisshoff H; Seifert U; Drung I; Mügge C; Sijts A; Kloetzel PM; Kuckelkorn U
    J Biol Chem; 2007 Apr; 282(17):12749-54. PubMed ID: 17308306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
    Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
    Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.
    Shimbara N; Nakajima H; Tanahashi N; Ogawa K; Niwa S; Uenaka A; Nakayama E; Tanaka K
    Genes Cells; 1997 Dec; 2(12):785-800. PubMed ID: 9544705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition.
    Keller M; Ebstein F; Bürger E; Textoris-Taube K; Gorny X; Urban S; Zhao F; Dannenberg T; Sucker A; Keller C; Saveanu L; Krüger E; Rothkötter HJ; Dahlmann B; Henklein P; Voigt A; Kuckelkorn U; Paschen A; Kloetzel PM; Seifert U
    Eur J Immunol; 2015 Dec; 45(12):3257-68. PubMed ID: 26399368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.
    Dick TP; Ruppert T; Groettrup M; Kloetzel PM; Kuehn L; Koszinowski UH; Stevanović S; Schild H; Rammensee HG
    Cell; 1996 Jul; 86(2):253-62. PubMed ID: 8706130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.
    de Graaf N; van Helden MJ; Textoris-Taube K; Chiba T; Topham DJ; Kloetzel PM; Zaiss DM; Sijts AJ
    Eur J Immunol; 2011 Apr; 41(4):926-35. PubMed ID: 21360704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinities.
    Riley JP; Rosenberg SA; Parkhurst MR
    J Immunol Methods; 2003 May; 276(1-2):103-19. PubMed ID: 12738363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the proteasome activator PA28 in MHC class I antigen processing.
    Sijts A; Sun Y; Janek K; Kral S; Paschen A; Schadendorf D; Kloetzel PM
    Mol Immunol; 2002 Oct; 39(3-4):165-9. PubMed ID: 12200048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context.
    Kuckelkorn U; Ferreira EA; Drung I; Liewer U; Kloetzel PM; Theobald M
    Eur J Immunol; 2002 May; 32(5):1368-75. PubMed ID: 11981824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.
    Sun Y; Song M; Stevanović S; Jankowiak C; Paschen A; Rammensee HG; Schadendorf D
    Int J Cancer; 2000 Aug; 87(3):399-404. PubMed ID: 10897046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of proline residue for efficient production of MHC class I ligands by proteasomes.
    Shimbara N; Ogawa K; Hidaka Y; Nakajima H; Yamasaki N; Niwa S; Tanahashi N; Tanaka K
    J Biol Chem; 1998 Sep; 273(36):23062-71. PubMed ID: 9722532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of proteasome activator PA28-beta subunit of large yellow croaker (Pseudosciana crocea) and its coordinated up-regulation with MHC class I alpha-chain and beta 2-microglobulin in poly I:C-treated fish.
    Liu G; Zheng W; Chen X
    Mol Immunol; 2007 Feb; 44(6):1190-7. PubMed ID: 16901544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
    Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
    J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-selective effect of PA28 in MHC class I antigen processing.
    Yamano T; Sugahara H; Mizukami S; Murata S; Chiba T; Tanaka K; Yui K; Udono H
    J Immunol; 2008 Aug; 181(3):1655-64. PubMed ID: 18641301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2.
    Noppen C; Lévy F; Burri L; Zajac P; Remmel E; Schaefer C; Lüscher U; Heberer M; Spagnoli GC
    Int J Cancer; 2000 Jul; 87(2):241-6. PubMed ID: 10861482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.
    Robson NC; McAlpine T; Knights AJ; Schnurr M; Shin A; Chen W; Maraskovsky E; Cebon J
    Blood; 2010 Jul; 116(2):218-25. PubMed ID: 20430956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
    J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate.
    Ben-Shahar S; Komlosh A; Nadav E; Shaked I; Ziv T; Admon A; DeMartino GN; Reiss Y
    J Biol Chem; 1999 Jul; 274(31):21963-72. PubMed ID: 10419519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).
    Parkhurst MR; Fitzgerald EB; Southwood S; Sette A; Rosenberg SA; Kawakami Y
    Cancer Res; 1998 Nov; 58(21):4895-901. PubMed ID: 9809996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.